Related Experiment Video
Updated: Feb 22, 2026
11:37
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
14.3K
Potential Role of OCT4 in Leukemogenesis
Tiphanie Picot1,2, Sanae Kesr1,2, Yuenv Wu1,2
11 Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Saint-Etienne , Saint-Etienne, France .
Stem Cells and Development
|September 16, 2017
Summary
OCT4, a gene linked to cancer, drives proliferation and prevents differentiation in acute myeloid leukemia (AML) cells. Inhibiting OCT4 promotes AML cell differentiation and reduces proliferation, suggesting it as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Stem Cell Biology
Background:
- Embryonic stem cells possess self-renewal and differentiation capabilities, regulated by transcription factors like OCT4.
- OCT4 is aberrantly expressed in various cancers, including acute myeloid leukemia (AML).
Purpose of the Study:
- To investigate the role of OCT4 in proliferation and differentiation arrest in acute myeloid leukemia (AML).
Main Methods:
- Assessed OCT4 expression, clonogenic, and proliferation properties in myeloid cell lines.
- Induced differentiation using retinoic acid (RA) and inhibited OCT4 using short hairpin RNA (shRNA).
Main Results:
- Retinoic acid (RA) decreased OCT4 expression, leading to differentiation, reduced proliferation, cell cycle arrest, and p21 upregulation in most AML cell lines.
- OCT4 inhibition via shRNA mimicked these differentiation and proliferation-inhibiting effects.
- KG1a cell line showed reduced proliferation but no differentiation, indicating varied responses.
Conclusions:
- OCT4 plays a role in differentiation arrest and proliferation in certain AML subtypes.
- OCT4 inhibition demonstrates potential as an antileukemic treatment strategy.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
01:06Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
02:40Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:21Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K